(Q48738872)

English

Effect of quetiapine and norquetiapine on anxiety and depression in major psychoses using a pharmacokinetic approach: a prospective observational study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/22299714

Effect of quetiapine and norquetiapine on anxiety and depression in major psychoses using a pharmacokinetic approach: a prospective observational study. (English)

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/22299714

Massimiliano Buoli

4

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/22299714

Bernardo Dell'Osso

object named as

Bernardo Dell'osso

5

0 references

author name string

A Carlo Altamura

1

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/22299714

Donatella Moliterno

2

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/22299714

Silvia Paletta

3

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/22299714

Massimo C Mauri

6

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/22299714

Silvio R Bareggi

7

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/22299714

publication date

1 March 2012

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/22299714

Clinical Drug Investigation

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/22299714

32

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/22299714

213-219

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/22299714

3

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/22299714

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

A preclinical and clinical rationale for quetiapine in mood syndromes

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

Spotlight on quetiapine in bipolar depression

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

Quetiapine XR: current status for the treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

Rapid titration versus conventional titration of quetiapine in the treatment of bipolar mania: a preliminary trial

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

Rapid dose titration of quetiapine for the treatment of acute schizophrenia and acute mania: a case series

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

N-desalkylquetiapine activates ERK1/2 to induce GDNF release in C6 glioma cells: a putative cellular mechanism for quetiapine as antidepressant

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

Two weeks' quetiapine treatment for schizophrenia, drug-induced psychosis and borderline personality disorder: a naturalistic study with drug plasma levels.

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels.

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

Quetiapine in combination with citalopram in patients with unipolar psychotic depression

1 reference

https://api.crossref.org/works/10.2165%2F11597330-000000000-00000

21 January 2018

Treatment of bipolar disorder: the evolving role of atypical antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/22299714

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22299714

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22299714

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled st

1 reference

https://pubmed.ncbi.nlm.nih.gov/22299714

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22299714

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of rapid dose administration of quetiapine in bipolar mania

1 reference

https://pubmed.ncbi.nlm.nih.gov/22299714

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic variability of quetiapine and the active metabolite N-desalkylquetiapine in psychiatric patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22299714

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atypical antipsychotics in bipolar depression: potential mechanisms of action.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22299714

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11597330-000000000-00000

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/22299714

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/22299714

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48738872&oldid=1727163184"